Craniomaxillofacial Devices Market Size By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, Bone Graft Substitute System), By Implant Type (Standard Implants, Customized/Patient-specific Implants), By Location (Internal Fixators, External Fixators), By Materials (Metals, Bioabsorbable Materials, Ceramics, Polymers), By Application (Trauma Reconstruction Surgery, Orthognathic Surgery, Plastic Surgery), By Resorbability (Resorbable Fixators, Non- Resorbable Fixators), By End-use (Hospitals, Ambulatory Surgery Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026
Published Date: Mar 2020 | Report ID: GMI432 | Authors: Sumant Ugalmugle, Rupali Swain
Craniomaxillofacial Devices Market size was valued over USD 1.3 billion in 2019 and is expected to witness more than 7% CAGR from 2020 to 2026. Increasing incidences of facial injuries caused due to traffic accidents, sport injuries, falls, assaults and motor car accidents is driving the global market growth. Moreover, introduction of minimally invasive maxillofacial surgery will boost the demand for craniomaxillofacial devices.
Get more details on this report - Request Free Sample PDF
The use of minimally invasive procedures in reconstruction surgeries owing to several advantages such as minimum blood loss and pain along with, faster rehabilitation, shorter hospital stays, and rapid improvement will boost the craniomaxillofacial devices industry growth.
The demand is gradually shifting from traditional open surgery to the use of less invasive techniques for reconstruction surgeries. Increase in preference of surgeons and patients for minimally invasive surgical procedures along with several applications of newer technologies will play major role in augmenting the business growth.
|Base Year:||2019||Market Size in 2019:||1,382.1 Million (USD)|
|Historical Data for:||2015 to 2019||Forecast Period:||2020 to 2026|
|Forecast Period 2020 to 2026 CAGR:||7.0%||2026 Value Projection:||2,209.0 Million (USD)|
|Pages:||400||Tables, Charts & Figures:||874|
|Geographies covered (52):||U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, Ukraine, China, Japan, India, Australia, South Korea, Taiwan, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Brazil, Mexico, Argentina, Colombia, Peru, Chile, South Africa, Saudi Arabia, UAE, Qatar, Kuwait, Israel|
|Segments covered:||Product, Implant Type, Location, Materials, Application, Resorbability and End-use|
|Companies covered (12):||B. Braun Melsungen AG (Aesculap Implant Systems, Inc.), Cavendish Implants Ltd., CONMED Corporation, Integra Life Sciences, Johnson and Johnson, KLS Martin L.P., Medartis AG, Medtronic, OsteoMed, Stryker Corporation, TMJ Concepts, Zimmer Biomet Holdings, Inc.|
|Pitfalls & Challenges:||
Rising number of patients suffering from maxillofacial injuries and fractures will boost the demand for craniomaxillofacial devices
Increase in number of people suffering from cranial, maxillofacial injuries will be one of the major factors driving the market growth in the upcoming years. The number of cases of craniofacial fractures vary from country to country on the basis of several demographic and socioeconomic factors.
According to the recent research study, the prevalence of craniomaxillofacial injuries is higher in males than in females. Increase in number of traffic road accidents, falls, domestic assaults, car accidents and sport injuries will play a major role in enhancing the market growth.
Rising preference for minimally invasive trauma reconstruction procedures instead of traditional methods will increase the demand and adoption rate of craniomaxillofacial surgeries thereby, fuelling the industry growth. As per a recent research article, patient-centric benefits as well as recognized healthcare cost savings has resulted in introduction of minimally invasive surgical procedures.
Therefore, recent technological advancements in manufacturing of devices and conducting surgeries will augment the craniomaxillofacial devices market growth in the upcoming years.
However, high cost of the craniomaxillofacial devices and surgeries will be one of the major market impeding factors. The craniomaxillofacial surgeries are expensive and unaffordable to the patients of low and middle income countries.
Increasing number of craniomaxillofacial surgeries across the globe will spur the market growth
Get more details on this report - Request Free Sample PDF
Temporomandibular joint replacement system segment is projected to grow at over 10% during the forecast time period. The main indication for the use of temporomandibular joint replacement is in case of severely damaged mandibular joint. Increase in number of temporomandibular joint fracture cases owing to traumatic accidents, fall and assaults will result in augmenting the craniomaxillofacial devices market demand in the near future.
Growing cases of facial deformities will propel the demand for standard craniomaxillofacial implants
Standard implants segment was valued around USD 900 million in 2019 and projected to hold significant share over the estimation period. With several rapid innovations, companies have made a significant contribution in manufacturing technologically advanced craniomaxillofacial devices for standard use in operating rooms across the globe.
As per the recent research article, improvisation in standard implants has resulted in minimal problems associated with craniomaxillofacial devices. The aforementioned factors will play pivotal role in enhancing the craniomaxillofacial devices industry growth.
Growing use of internal fixators for minimally invasive surgical procedures will boost the craniomaxillofacial devices market growth
Internal fixators segment held the majority market share and was valued over USD 1,000 million in 2019. Increase in use of internal fixation techniques by surgeons in order to reduce the operative complications by minimizing soft-tissue disruption will increase the adoption of craniomaxillofacial devices. Recent technological developments in manufacturing of novel products and treatment of craniomaxillofacial injuries will drive the industry growth.
Use of advanced bioabsorbable materials is expected to augment the product adoption
Bioabsorbable materials segment is projected to grow at more than 7.5% over the forecast period. Increase in demand and adoption rate of bioabsorbable devices in the last few years will boost the business growth. The devices are made of polyglycolic acid and/or polymers polylactic acid that provide efficient treatment in case of craniomaxillofacial fractures.
Increase in number of facial trauma cases will boost the demand for craniomaxillofacial devices
The use of craniomaxillofacial devices is more in trauma reconstructive surgeries and the segment was valued at over USD 550 million in 2019. Growing use of craniomaxillofacial devices for the treatment of maxillofacial and craniofacial trauma will result in augmenting the demand and adoption rate of the craniomaxillofacial devices, enhancing the industry growth over 2020 to 2026.
Increase in use of technological advanced and revolutionary technique will enhance the resorbable fixators market growth
Get more details on this report - Request Free Sample PDF
Resorbable fixators segment is projected to grow at around 7.3% over the estimation period. Resorbable fixators are revolutionary devices for the use in craniomaxillofacial surgeries. The resorbable meshes are heated up and moulded in shape to fit the application site.
Also, the resorbable fixators are convenient, fast, easy and safe to use. They are designed for cranial fixation, pediatric trauma, and indicated also for cancellous bone structures.
Presence of skilled professionals and recent technologies will enhance the market growth
Hospitals segment held the majority market share and was valued over USD 800 million in 2019. Majority of craniomaxillofacial surgeries are conducted in hospitals, owing to the presence of technologically advanced devices and skilled professionals in these healthcare settings. Also, several additional provisions such as intensive care units and post-surgical support will fuel the craniomaxillofacial devices market share.
Presence of major industry players and growing cases of facial trauma in the U.S. will boost the market growth
Regionally, North America held more than 50% market share and the U.S. craniomaxillofacial devices market was valued more than USD 650 million in 2019. Increase in number of congenital facial deformities among the newborns in the U.S. will augment the market growth.
As per the statistics published by the Arnold Palmer Hospital, more than 6,000 infants are born with congenital facial deformities such as cleft palate or cleft lip that requires craniomaxillofacial surgical procedures. Also, increase in number of accidental trauma cases and traffic accidents in the country will result in enhancing the market growth in the region.
Germany CMF devices market held the largest revenue share in 2019 and was valued at more than USD 60 million. Growing facial trauma cases coupled with rising number of plastic surgeries will fuel the market growth. Germany incidentally, houses one of the top leading hospitals for craniomaxillofacial surgeries.
Execution of strategies such as partnerships and collaborations by major industry players will boost the market share
Some of the major key players operating in the craniomaxillofacial devices market share are KLS Martin LP, Stryker Corporation, Zimmer-Biomet, Inc. and Medtronic among others. These major companies are implementing several important strategic decisions such as mergers, acquisitions, collaborations and partnerships in order to expand their product portfolio and geographic reach. Also, product innovation and new product launches will benefit the companies in consolidating their market position.
Recent industry developments:
- In April 2018, Medtronic’s Infuse Bone Graft received FDA approval. This approval enabled Medtronic to cater to oral-maxillofacial surgery patients, thus broadening its product portfolio and customer base.
- In October 2017, the company acquired Johnson & Johnson Codman Neurosurgery business. This acquisition helped diversify its product portfolio and generate more revenue.
The craniomaxillofacial devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
Market Outlook By Product
- MF Plate and Screw Fixation System
- Cranial Flap Fixation System
- CMF Distraction System
- Temporomandibular Joint Replacement System
- Thoracic Fixation System
- Bone Graft Substitute System
Analysis By Implant Type
- Standard Implants
- Customized/Patient-specific Implants
- Internal Fixators
- External Fixators
- Bioabsorbable Materials
- Trauma Reconstruction Surgery
- Orthognathic Surgery
- Plastic Surgery
- Resorbable Fixators
- Non- Resorbable Fixators
- Ambulatory Surgery Centers
The above information is provided for the following regions and countries:
- North America
- Czech Republic
- Asia Pacific
- South Korea
- New Zealand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
Frequently Asked Questions (FAQ) :
Take a free trial of GMIPuse, our report store; designed to provide clients a range of market research services, all on a single platform.Start Your Free Trial
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.